Previous close | 9.30 |
Open | 9.21 |
Bid | 9.66 x 100 |
Ask | 9.83 x 100 |
Day's range | 9.21 - 10.22 |
52-week range | 1.52 - 12.35 |
Volume | |
Avg. volume | 191,148 |
Market cap | 319.552M |
Beta (5Y monthly) | 1.34 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.16 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Sera Prognostics, Inc. (NASDAQ:SERA) Q1 2024 Earnings Call Transcript May 8, 2024 Sera Prognostics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to the Sera Prognostics Conference Call to Review First Quarter Fiscal Year 2024 […]
Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced financial results for the first quarter of 2024 ended March 31, 2024.
Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that it will report first quarter fiscal year 2024 financial results on Wednesday, May 8, 2024, after the close of the market. The Company will host a corresponding conference call and live webcast to discuss operational highlights, financial results and key topics at 5:00 p.m. Eastern Time